Microfluidic Immunoassay Analyzer - ToronMIA™
ToronMIA™ Microfluidic Immunoassay Analyzer combines advanced microfluidic technology with highly sensitive time-resolved fluorescence immunoassay to deliver lab-grade results at the point of care.
This compact, user-friendly desktop analyzer delivers accurate diagnostic results (CV ≤ 6%) in under 12 minutes, helping healthcare professionals make timely and cost-effective treatment decisions.
The platform is built for scalability, with the potential to become one of the most versatile testing systems in the point-of-care market.
Operation Procedure
Perfect Performance
Application
- Hospitals & Emergency Departments - Provides rapid diagnostic results for critical biomarkers such as cardiac troponins, NT-proBNP, and D-dimer to support timely decision-making in emergency and acute care settings.
Point-of-Care Testing (POCT) Facilities - Offers lab-grade accuracy in decentralized locations, enabling physicians and clinicians to perform fast and reliable tests without the need for central laboratory support.
Cardiology & Cardiovascular Clinics - Used for routine monitoring and rapid assessment of cardiac markers including hs-cTnT, CK-MB, and BNP/NT-proBNP for early detection and management of heart failure, myocardial infarction, and related conditions.
Intensive Care Units (ICUs) & Critical Care - Delivers fast results for inflammation and infection markers such as IL-6 and PCT, supporting immediate intervention in sepsis and systemic inflammatory response cases.
Diagnostic Laboratories - Complements central lab operations by providing quick-turnaround testing for urgent samples, reducing workload and improving workflow efficiency.
Primary Care & Community Health Centers - Enables general practitioners to conduct on-site biomarker testing for cardiovascular and inflammatory conditions, improving patient care and reducing hospital referrals.
Ambulatory & Mobile Healthcare Services - Compact and lightweight design makes it suitable for use in mobile clinics, field hospitals, and remote healthcare settings requiring reliable diagnostics.
Research Institutions & Clinical Trials - Facilitates biomarker monitoring in studies related to cardiovascular health, inflammation, and sepsis with precise, repeatable quantitation in a portable format.
Pharmaceutical & Biotech Companies - Supports drug development and monitoring by providing rapid, accurate biomarker testing for clinical research and therapeutic evaluations.
- Simple
All in One Disc, Sample in, Result out - Save Time
Turnaround time (TAT) under 12 minutes - Save Sample
Requires only 50 µL of whole blood or plasma - Precise Quantitation
Built-in centrifuge ensures accurate plasma separation, reducing errors from varying hematocrit (HCT) levels - High Sensitivity
Performance on par with chemiluminescence methods - Adjustable Throughput
Run 1 to 6 time-resolved fluorescence immunoassays in a single cycle - Easy to Use
No external calibration needed, minimal maintenance - Compact Design
- Dimensions: 285 mm (L) × 235 mm (W) × 155 mm (H)
- Weight: Only 3.2 kg
- Reliable Connectivity
Compatible with LIS and HIS systems
Test Menu
| Usage | Panel | Test Items |
| Inflammation | Procalcitonin (PCT) (Microfluidic time resolved fluoroimmunoassay) | PCT* |
| Interleukin 6 (IL-6) (Microfluidic time resolved fluoroimmunoassay) | IL-6* | |
| Cardiovascular | hs-Cardiac Troponin T (hs-cTnT) (Microfluidic time resolved fluoroimmunoassay) | hs-cTnT* |
| Cardiac Troponin T (cTnT) (Microfluidic time resolved fluoroimmunoassay) | Troponin T* | |
| Myoglobin (Myo) (Microfluidic time resolved fluoroimmunoassay) | Myo* | |
| Creatine Kinase MB (CK-MB) (Microfluidic time resolved fluoroimmunoassay) | CK-MB* | |
| N-terminal pro b-type natriuretic peptide (NT-proBNP) (Microfluidic time resolved fluoroimmunoassay) | NT-proBNP* | |
| B-type Natriuretic Peptide (BNP) (Microfluidic time resolved fluoroimmunoassay) | BNP* | |
| D-Dimer (Microfluidic time resolved fluoroimmunoassay) | D-Dimer* |
*CE Marked